Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aventis Diabetes Outlook: Lantus Has Brighter Future Than Exubera, Firm Says

Related Content

Pfizer’s Friendly Tack: McKinnell Shares Credit With Hassan, Offers No. 2 Spot

Jul 22 2002

Pfizer/Aventis Exubera NDA Delayed Until 2002; FDA May Require More Data

Jul 23 2001

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window